Trials / Terminated
TerminatedNCT03240679
Endoscopic Mucosal Resection and Cellular Matrix
A Randomized Study of Biologic Scaffolds And Esophageal Healing Following Endoscopic Resection
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is being done to test the usefulness of extracellular matrix (ECM) a thin sheet placed over the site after endoscopic mucosal resection to promote healing of the esophagus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Acell MatriStem® Surgical Matrix | Extracellular matrix (ECM) product that is composed of collagen and natural proteins that provide a re-absorbable scaffold for tissue remodeling to facilitate constructive healing following endoscopic submucosal resection (EMR). Covers the defect site following mucosal resection using endoscopy clips or X-tac. The device will remain attached to the esophagus and integrate with native tissue over time. |
Timeline
- Start date
- 2017-03-22
- Primary completion
- 2017-06-20
- Completion
- 2017-06-20
- First posted
- 2017-08-07
- Last updated
- 2023-02-06
- Results posted
- 2023-02-06
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03240679. Inclusion in this directory is not an endorsement.